Abstract:Agomelatine is an antidepressant with a unique pharmacological profile, it acting as an agonist of MT1 and MT2 melatoninergic receptors and as an antagonist of the 5-HT2C receptor. The drug has a quick onset of action and a long maintenance of the therapeutic effect, also it is well tolerated. In clinical studies in patients with depression agomelatine reduces anxiety symptoms and improves sleep quality, not causing sedation, weight gain, sexual dysfunction or suppression of emotional responses.

The use of agomelatine in the reduction of anhedonia and sleep disorders in the course of depression